is noom glp 1 safe upgrades GLP-1 weight management app features as digital therapeutics gain US market traction Noom: Lose weight and keep
Description
GLP-1 Receptor Agonist Market was valued at USD 27.27 Billion in 2025 and is expected to reach USD 138.15 Billion by 2035, growing at a CAGR of 17.61% from 20262035
Each location offers unique benefits and considerations, but the decision will often come down to factors such as convenience, comfort, and individual patient needs
Ready to explore if GLP1 medications could be right for you
According to Yale Medicine, about 15% of couples in the U.S
[DOI] [PMC free article] [PubMed] [Google Scholar] 8.Kim Y.H., Kim S.M., Han K.D., Jung J.H., Lee S.S., Oh S.W., Park H.S., Rhee E.J., Lee W.Y., Yoo S.J
